Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
Release time:
2020-08-14
Jianfeng Pharmaceutical Invests in Shanghai Beika
to Build API R & D and Production Base
News # October 19 , the Group Company Held the Second Meeting of the 10th Board of Directors and deliberated and passed the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical". On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital.
Shanghai North Carolina is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include anti-tumor drug intermediates such as tinib, alkaloids, sugars, etc. The customized services are mainly CDMO (contract development and manufacturing) for new drugs and intermediates.
Shanghai North Carolina has two wholly-owned subsidiaries: Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide production enterprise designated by the Ministry of Industry and Information Technology. It was established in 2007 7 . It now has three chemical synthesis workshops and one pesticide formulation workshop, with 10 product approval documents and 13 patents. Anhui North Carolina was established in 2016 12 . Its business scope includes customization, production and sales of chemical bulk drugs and pharmaceutical intermediates, wholesale and retail of chemical raw materials and products (except hazardous chemicals), etc. It has also been approved to undertake the "Small Molecule Targeted Drug Manufacturing Base", a major emerging industry project in Anhui Province ". After the cooperation is reached, Changtai Chemical will further extend to the direction of pharmaceutical intermediates on the basis of its existing business. Anhui North Carolina will be built into a production base based on pharmaceutical raw materials to undertake the transformation of Shanghai North Carolina's achievements.
This cooperation is an important measure to strengthen the development of the pharmaceutical business sector according to the company's strategic policy of "strengthening the main business through cooperation and innovation, standardizing science and seeking development". If the cooperation can be successfully completed, Shanghai Beika and its subsidiaries will become the holding subsidiaries of Jianfeng Pharmaceutical. Spike Pharmaceuticals will use Shanghai Beika and its subsidiaries as a platform to establish a research and development and production base for APIs and intermediates, further extend and improve the industrial chain, increase the scale of the industry, improve research and development capabilities, and provide a reliable guarantee for the production of APIs for Spike Pharmaceuticals, thereby enhancing the comprehensive strength of Spike Pharmaceuticals. (Zhou Hengbin)
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page